Literature DB >> 12237218

Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic template.

David F V Lewis1.   

Abstract

A historical background to homology modelling of human P450s involved in drug metabolism is outlined, showing that the progress in crystallographic studies of bacterial forms of enzyme and, latterly, determination of a mammalian P450 crystal structure, has enabled the production of increasingly satisfactory models of human P450 enzymes. The methodology for the generation of P450 models by homology with crystallographic template structures is summarized, and recent results of CYP2C5-constructed models of P450s are described. These indicate that selective substrates are able to fit within the putative active sites of each enzyme, where key contacts with complementary amino acid residues are largely consistent with the results of site-directed mutagenesis experiments and metabolic studies. Consequently, the CYP2C5 crystal structure can be regarded at the current paradigm for homology modelling of the drug metabolizing P450s, especially those from the CYP2 family.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237218     DOI: 10.1016/s0162-0134(02)00429-4

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  6 in total

1.  Investigation of the role of cytochrome P450 2B4 active site residues in substrate metabolism based on crystal structures of the ligand-bound enzyme.

Authors:  Cynthia E Hernandez; Santosh Kumar; Hong Liu; James R Halpert
Journal:  Arch Biochem Biophys       Date:  2006-09-25       Impact factor: 4.013

2.  Studies of binding modes of (S)-mephenytoin to wild types and mutants of cytochrome P450 2C19 and 2C9 using homology modeling and computational docking.

Authors:  Akifumi Oda; Noriyuki Yamaotsu; Shuichi Hirono
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

3.  Quantitative structure-activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s.

Authors:  David F V Lewis
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

4.  Kinetic and molecular analysis of 5-epiaristolochene 1,3-dihydroxylase, a cytochrome P450 enzyme catalyzing successive hydroxylations of sesquiterpenes.

Authors:  Shunji Takahashi; Yuxin Zhao; Paul E O'Maille; Bryan T Greenhagen; Joseph P Noel; Robert M Coates; Joe Chappell
Journal:  J Biol Chem       Date:  2004-11-02       Impact factor: 5.157

Review 5.  Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors.

Authors:  Zbigniew Dutkiewicz; Renata Mikstacka
Journal:  Bioinorg Chem Appl       Date:  2018-07-25       Impact factor: 7.778

Review 6.  Utility of homology models in the drug discovery process.

Authors:  Alexander Hillisch; Luis Felipe Pineda; Rolf Hilgenfeld
Journal:  Drug Discov Today       Date:  2004-08-01       Impact factor: 7.851

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.